Thanks Pedro....I'm not seeing a share issue in this ............Why?....There is a lot of shares held by the directors and I wonder if they could come up with the cash.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%